Sio Gene Therapies Inc. Common Stock
SIOX
SIOX was delisted on the 22nd of March, 2023.
48 hedge funds and large institutions have $21.8M invested in Sio Gene Therapies Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
60% more call options, than puts
Call options by funds: $3.49M | Put options by funds: $2.18M
23% more funds holding
Funds holding: 39 → 48 (+9)
14% more capital invested
Capital invested by funds: $19.1M → $21.8M (+$2.66M)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$917K |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$612K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$540K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$449K |
| 5 |
Axa
Paris,
France
|
+$352K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$379K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$362K |
| 3 |
Renaissance Technologies
New York
|
-$357K |
| 4 |
Jane Street
New York
|
-$289K |
| 5 |
LI
Leap Investments
Chicago,
Illinois
|
-$115K |
SIOX Hedge Fund Activity: Q3 2019 in Review
48 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q3 2019, worth a combined $21.8M — up 14% from $19.1M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new SIOX positions and 5 closed out — a net gain of 9 holders — while 8 added to existing stakes and 11 trimmed.
The largest buyer was Caption Management, opening a new position worth an estimated $917K. The largest seller was Hudson Bay Capital Management, cutting an estimated $379K.
- 48 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q3 2019, up from 39 in Q2 2019.
- Funds reported $21.8M of Sio Gene Therapies Inc. Common Stock stock for Q3 2019, up 14% quarter-over-quarter.
- 14 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q3 2019 and 5 closed out, a net change of +9 holders.
- The largest Sio Gene Therapies Inc. Common Stock buyer in Q3 2019 was Caption Management, an estimated $917K added.
- The largest Sio Gene Therapies Inc. Common Stock seller in Q3 2019 was Hudson Bay Capital Management, an estimated $379K sold.
Based on aggregated 13F filings for Q3 2019.